SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DanZ who wrote (1217)10/29/1999 12:17:00 AM
From: Bo Didley  Read Replies (1) of 5582
 
Dan, I'm looking forward to those future earnings which will propel GUMM to $100+.
Message 11727965

Obviously it won't be the report coming up.
messages.yahoo.com

Most of the GUMM investors I know are in for the long haul
and have no time line or price to sell. After the $100 it will keep going higher as new products come out of their research labs. There are whole bunch of drugs that can be best delivered through chewing gum.

We are not investing in rumors, but a new delivery mode for drugs.

As Street Walker said:
>What will GUMM come up with next? The FUNCTIONAL chewing gum market is an innovative means for drug delivery. Gary is the world specialist in gum formulation and it would not suprise me to see other 'joint ventures' to form in years to come with well recognized big pharma.

A stock price in the hundreds would not suprise me in the least in years to come.<

Chewing gum as a delivery mode for drugs, vitamins, etc. That is what we are invested in, as well as Zicam.

bo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext